Endpoints News· Kyle LaHucik·· 1 小时前AI 评分33
北京 BioGeometry 完成超 1 亿美元 A 轮融资，用于 AI 药物研发
Beijing-based BioGeometry gets $100M+ for AI drug R&D
AI 导读
总部位于北京的 BioGeometry 完成超 1 亿美元 A 轮融资，资金用于其 AI 驱动的蛋白质设计。该公司成立 4 年，专注 AI 药物研发。
正文 · 原文
A Chinese biotech startup has raised more than $100 million in Series A funding for its AI-driven protein design.
BioGeometry, a 4-year-old company headquartered in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news